These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1356731)
1. Metabolism of [14C]azelastine in guinea pigs. Yang JT; Wong KK; Kucharczyk N; Sofia RD Drug Metab Dispos; 1992; 20(4):536-40. PubMed ID: 1356731 [TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and lung localization of [14C]azelastine in guinea pigs. Wong KK; Yang JT; Kucharczyk N; Sofia RD Drug Metab Dispos; 1992; 20(4):525-9. PubMed ID: 1356729 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of azelastine and its active metabolite, desmethylazelastine, in guinea pigs. Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD Drug Metab Dispos; 1992; 20(4):530-5. PubMed ID: 1356730 [TBL] [Abstract][Full Text] [Related]
4. High performance liquid chromatographic determination of azelastine and desmethylazelastine in guinea pig plasma and lung tissue. Langevin CN; Pivonka J; Wichmann JK; Kucharczyk N; Sofia RD Biomed Chromatogr; 1993; 7(1):7-11. PubMed ID: 8094306 [TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic and pharmacokinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung. Chand N; Adusumalli VE; Nolan K; Diamantis W; Wichmann JK; Pivonka J; Langevin CN; Wong KK; Kucharczyk N; Sofia RD Allergy; 1993 Jan; 48(1):19-24. PubMed ID: 8096126 [TBL] [Abstract][Full Text] [Related]
10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat. Koble DL; Koons JC; Fischer LJ Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549 [TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone. Prakash C; Kamel A; Anderson W; Howard H Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052 [TBL] [Abstract][Full Text] [Related]
16. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
17. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905 [TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713 [TBL] [Abstract][Full Text] [Related]
20. Effect of azelastine on the down regulation of beta-adrenoceptors in guinea pig lung. Yin KS; Hayashi K; Taki F; Watanabe T; Takagi K; Satake T Arzneimittelforschung; 1991 May; 41(5):525-7. PubMed ID: 1680326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]